Can direct-to-consumer advertising of prescription drugs be effectively regulated?

ResearchSpace/Manakin Repository

Show simple item record

dc.contributor.author Lexchin, J en
dc.contributor.author Menkes, David en
dc.date.accessioned 2019-10-08T08:13:56Z en
dc.date.issued 2019-06-07 en
dc.identifier.citation New Zealand Medical Journal 132(1496):59-65 07 Jun 2019 en
dc.identifier.issn 0028-8446 en
dc.identifier.uri http://hdl.handle.net/2292/48435 en
dc.description.abstract The government of New Zealand is currently considering a new Therapeutic Products Regulatory Scheme that includes how direct-to-consumer advertising (DTCA) of prescription drugs should be regulated. This article reviews three different types of possible regulation of DTCA: government regulation, industry self-regulation and a mixture of the two. Recent studies demonstrate that DTC ads in the US continue to be misleading and contain minimal if any educational value, despite governmental regulatory efforts by the Food and Drug Administration. Other regulatory models are equally unsuccessful at controlling DTCA. Available evidence suggests that DTC ads are commonly misinterpreted as trusted public health messages and are more likely to affect vulnerable subgroups of New Zealanders. Taken together with the international evidence that regulation has consistently failed to prevent the inappropriate promotion of prescription medicines, these findings suggest that DTCA is more likely to cause harm than benefit and should be banned. en
dc.publisher New Zealand Medical Association en
dc.relation.ispartofseries New Zealand Medical Journal en
dc.rights Items in ResearchSpace are protected by copyright, with all rights reserved, unless otherwise indicated. Previously published items are made available in accordance with the copyright policy of the publisher. en
dc.rights.uri https://researchspace.auckland.ac.nz/docs/uoa-docs/rights.htm en
dc.rights.uri https://www.nzma.org.nz/journal/contribute en
dc.title Can direct-to-consumer advertising of prescription drugs be effectively regulated? en
dc.type Journal Article en
pubs.issue 1496 en
pubs.begin-page 59 en
pubs.volume 132 en
dc.rights.holder Copyright: New Zealand Medical Association en
pubs.author-url https://www.nzma.org.nz/journal/read-the-journal/all-issues/2010-2019/2019/vol-132-no-1496-7-june-2019/7900 en
pubs.end-page 65 en
dc.rights.accessrights http://purl.org/eprint/accessRights/OpenAccess en
pubs.subtype Article en
pubs.elements-id 774554 en
pubs.org-id Medical and Health Sciences en
pubs.org-id School of Medicine en
pubs.org-id Psychological Medicine Dept en
pubs.record-created-at-source-date 2019-06-15 en
pubs.dimensions-id 31170134 en


Full text options

Find Full text

This item appears in the following Collection(s)

Show simple item record

Share

Search ResearchSpace


Advanced Search

Browse